Cytokinetics Forms $725M Heart Disease Alliance With Amgen Jan. 4, 2007 By Karen Carey Providing leverage for a small-molecule program targeted at heart failure, Cytokinetics Inc. is collaborating with Amgen Inc. in a deal potentially worth $725 million. (BioWorld Today)Read More
